Oligodendroglioma screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Oligodendroglioma}} {{CMG}}{{AE}}{{SR}} ==Overview== There is insufficient evidence to recommend routine screening for gliomatosis cerebri.<ref name=screen>Early..." |
No edit summary |
||
| Line 11: | Line 11: | ||
==References== | ==References== | ||
{{reflist|1}} | |||
{{ | [[Category:Neurological disorders]] | ||
[[Category:Types of cancer]] | |||
[[Category:Neurosurgery]] | |||
[[Category:Disease]] | |||
[[Category:Mature chapter]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Revision as of 19:57, 8 October 2015
|
Oligodendroglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oligodendroglioma screening On the Web |
|
American Roentgen Ray Society Images of Oligodendroglioma screening |
|
Risk calculators and risk factors for Oligodendroglioma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
There is insufficient evidence to recommend routine screening for gliomatosis cerebri.[1]
Screening
There is insufficient evidence to recommend routine screening for gliomatosis cerebri.[1]
References
- ↑ 1.0 1.1 Early detection, diagnosis, and staging of brain tumors. American cancer society. http://www.cancer.org/cancer/braincnstumorsinadults/detailedguide/brain-and-spinal-cord-tumors-in-adults-detection